A new study in Nature Cancer found that montelukast, a common asthma drug, blocks a molecule called CysLTR1 that tumours use ...
Older adults with joint pain are also more likely to be taking multiple prescribed medicines. Taking ibuprofen alongside ...
New results from the Phase 3 SUNRISE clinical trial show that tezepelumab significantly reduced the need for long-term oral ...
Altesa BioSciences, a clinical-stage pharmaceutical company dedicated to improving the lives of people with chronic lung diseases including COPD and asthma, today announced two key additions to the ...
New results from the Phase III SUNRISE clinical trial show that tezepelumab significantly reduced the need for long-term oral corticosteroid use in adults with severe oral corticosteroid-dependent ...
Breathlessness during walking is often mistaken for fatigue, aging, or a heart problem. However, experts say lung diseases ...
Explore the hidden dangers of allergies, their unpredictable triggers, and the urgent need for awareness and research in ...
Nasus Pharma Ltd. (NYSE: NSRX) ('Nasus Pharma” or the 'Company”), a clinical-stage pharmaceutical company focused on the ...
Allergies affect 30% of adults and 40% of children in the United States. But staying indoors is often not an option, ...
Daily Mail on MSN
NHS spending on blockbuster weight loss jab soars four-fold in a year to over half a billion pounds
Prescriptions for Mounjaro, which is also known as tirzepatide or the 'King Kong' of weight loss jabs, rose from 1.1million ...
Heatwaves, worsening air pollution, allergens and changing weather patterns are increasing respiratory illnesses across India ...
A large phase 3 clinical trial has revealed promising results for a once-nightly pill designed to treat obstructive sleep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results